141 related articles for article (PubMed ID: 26867671)
21. [Analysis of the causes of death in the treatment of hematological malignancies with allogeneic stem cell transplantation from sibling donor].
Yang SL; Li QC; Lai YR
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):120-1. PubMed ID: 21429381
[No Abstract] [Full Text] [Related]
22. [Allogeneic hematopoietic stem cell transplantation for acute myeloblastic leukemia in first remission].
Bondarenko SN; Semenova EV; Vavilov VN; Stancheva NV; Morozova EV; Alianskiĭ AL; Babenko EV; Osipova NÉ; Zubarovskaia LS; Afanas'ev BV
Ter Arkh; 2013; 85(7):18-25. PubMed ID: 24137943
[TBL] [Abstract][Full Text] [Related]
23. Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Takami A; Yano S; Yokoyama H; Kuwatsuka Y; Yamaguchi T; Kanda Y; Morishima Y; Fukuda T; Miyazaki Y; Nakamae H; Tanaka J; Atsuta Y; Kanamori H
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1785-90. PubMed ID: 25034960
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic hematopoietic stem cell transplantation and the risk for transmission of heritable malignancy.
McMilin KD
Transfusion; 2002 Apr; 42(4):495-504. PubMed ID: 12076299
[No Abstract] [Full Text] [Related]
25. Outcome of non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from family donors in children and adolescents.
Yoshihara T; Okada K; Kobayashi M; Kikuta A; Kato K; Adachi N; Kikuchi A; Ishida H; Hirota Y; Kuroda H; Nagatoshi Y; Inukai T; Koike K; Kigasawa H; Yagasaki H; Tokuda K; Kishimoto T; Nakano T; Fujita N; Goto H; Nakazawa Y; Kanegane H; Matsuzaki A; Osugi Y; Hasegawa D; Uoshima N; Nakamura K; Tsuchida M; Tanaka R; Watanabe A; Yabe H
Int J Hematol; 2007 Apr; 85(3):246-55. PubMed ID: 17483063
[TBL] [Abstract][Full Text] [Related]
26. The cell composition of infused donor lymphocyte has different impact in different types of allogeneic hematopoietic stem cell transplantation.
Zhao XS; Wang Y; Yan CH; Wang JZ; Zhang XH; Xu LP; Liu KY; Huang XJ
Clin Transplant; 2014 Aug; 28(8):926-34. PubMed ID: 24931494
[TBL] [Abstract][Full Text] [Related]
27. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
[TBL] [Abstract][Full Text] [Related]
28. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Wang JZ; Gao ZY; Zhang YC; Jiang Q; Shi HX; Lu DP
Bone Marrow Transplant; 2006 Aug; 38(4):291-7. PubMed ID: 16883312
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of Cord Blood Transplantation as Salvage Therapy after Graft Failure or Relapse after Prior Allogeneic Transplantation.
Salit RB; Milano F; Delaney C
Biol Blood Marrow Transplant; 2016 Feb; 22(2):339-343. PubMed ID: 26485444
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies.
Paviglianiti A; Ruggeri A; Volt F; Sanz G; Milpied N; Furst S; Esquirol A; Arcese W; Picardi A; Ferra C; Ifrah N; Bourhis JH; Raj K; von dem Borne PA; Sica S; Menard AL; Bloor A; Kenzey C; Gluckman E; Rocha V
Br J Haematol; 2017 Dec; 179(5):790-801. PubMed ID: 29048109
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
[TBL] [Abstract][Full Text] [Related]
32. Sibling cord blood donor program for hematopoietic cell transplantation: the 20-year experience in the Rome Cord Blood Bank.
Screnci M; Murgi E; Valle V; Tamburini A; Pellegrini MG; Strano S; Corona F; Ambrogi EB; Girelli G
Blood Cells Mol Dis; 2016 Mar; 57():71-3. PubMed ID: 26852659
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
[TBL] [Abstract][Full Text] [Related]
34. Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor.
Martín-Donaire T; Rico M; Bautista G; Gonzalo-Daganzo R; Regidor C; Ojeda E; Sanjuán I; Forés R; Ruiz E; Krsnik I; Navarro B; Gil S; Magro E; Millán I; Sánchez R; Pérez-Sanz N; Panadero N; García-Marco JA; Cabrera R; Fernández MN
Bone Marrow Transplant; 2009 Aug; 44(4):213-25. PubMed ID: 19252533
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
[TBL] [Abstract][Full Text] [Related]
36. Impact of Ethnicity on Donor Search Results for Children Requiring Stem Cell Transplantation.
DiLabio J; Doyle J; Alexander S; Gupta S; Punnett A
J Pediatr Hematol Oncol; 2015 Apr; 37(3):e154-7. PubMed ID: 25333838
[TBL] [Abstract][Full Text] [Related]
37. Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors.
Yan CH; Liu DH; Xu LP; Liu KY; Zhao T; Wang Y; Chen H; Chen YH; Han W; Huang XJ
Clin Transplant; 2012; 26(6):868-76. PubMed ID: 22432715
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of donor lymphocyte infusion in patients after different types of allogeneic hematopoietic stem cell transplantation].
Slesarchuk OA; Babenko EV; Semenova EV; Bondarenko SN; Éstrina MA; Morozova EV; Paina OV; Vavilov VN; Smirnov BI; Zubarovskaia LS; Afanas'ev BV
Ter Arkh; 2013; 85(7):26-33. PubMed ID: 24137944
[TBL] [Abstract][Full Text] [Related]
39. Pediatric hematopoietic stem cell transplantation in China: Data and trends during 1998-2012.
Du H; Chen J; Qin M; Fang J; Li Z; Zhu Y; Sun X; Huang D; Yu J; Tang Y; Hu S; Li J; Zhang Z; Luan Z
Pediatr Transplant; 2015 Aug; 19(5):563-70. PubMed ID: 26058853
[TBL] [Abstract][Full Text] [Related]
40. Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.
Anandi P; Tian X; Ito S; Muranski P; Chokshi PD; Watters N; Chawla U; Hensel N; Stroncek DF; Battiwalla M; Barrett AJ
Cytotherapy; 2017 Jun; 19(6):735-743. PubMed ID: 28395942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
